Sugimoto H - Search Results

1

Frequent promoter methylation of M-cadherin in hepatocellular carcinoma is associated with poor prognosis.

Yamada S, Nomoto S, Fujii T, Takeda S, Kanazumi N, Sugimoto H, Nakao A. Yamada S, et al. Among authors: sugimoto h. Anticancer Res. 2007 Jul-Aug;27(4B):2269-74. Anticancer Res. 2007. PMID: 17695513 Free article.

2

The tumor suppressor NPRL2 in hepatocellular carcinoma plays an important role in progression and can be served as an independent prognostic factor.

Otani S, Takeda S, Yamada S, Sakakima Y, Sugimoto H, Nomoto S, Kasuya H, Kanazumi N, Nagasaka T, Nakao A. Otani S, et al. Among authors: sugimoto h. J Surg Oncol. 2009 Oct 1;100(5):358-63. doi: 10.1002/jso.21241. J Surg Oncol. 2009. PMID: 19274676

3

Autologous blood storage before hepatectomy for hepatocellular carcinoma.

Kato K, Nomoto S, Sugimoto H, Kanazumi N, Takeda S, Nakao A. Kato K, et al. Among authors: sugimoto h. Hepatogastroenterology. 2009 May-Jun;56(91-92):802-7. Hepatogastroenterology. 2009. PMID: 19621706

4

Detection of metallothionein 1G as a methylated tumor suppressor gene in human hepatocellular carcinoma using a novel method of double combination array analysis.

Kanda M, Nomoto S, Okamura Y, Nishikawa Y, Sugimoto H, Kanazumi N, Takeda S, Nakao A. Kanda M, et al. Among authors: sugimoto h. Int J Oncol. 2009 Sep;35(3):477-83. doi: 10.3892/ijo_00000359. Int J Oncol. 2009. PMID: 19639168

5

Leukemia inhibitory factor receptor (LIFR) is detected as a novel suppressor gene of hepatocellular carcinoma using double-combination array.

Okamura Y, Nomoto S, Kanda M, Li Q, Nishikawa Y, Sugimoto H, Kanazumi N, Takeda S, Nakao A. Okamura Y, et al. Among authors: sugimoto h. Cancer Lett. 2010 Mar 28;289(2):170-7. doi: 10.1016/j.canlet.2009.08.013. Epub 2009 Sep 3. Cancer Lett. 2010. PMID: 19733004

6

Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.

Nomoto S, Kanda M, Okamura Y, Nishikawa Y, Qiyong L, Fujii T, Sugimoto H, Takeda S, Nakao A. Nomoto S, et al. Among authors: sugimoto h. Ann Surg Oncol. 2010 Mar;17(3):923-32. doi: 10.1245/s10434-009-0790-0. Epub 2009 Nov 7. Ann Surg Oncol. 2010. PMID: 19898900

7

Reduced expression of reelin (RELN) gene is associated with high recurrence rate of hepatocellular carcinoma.

Okamura Y, Nomoto S, Kanda M, Hayashi M, Nishikawa Y, Fujii T, Sugimoto H, Takeda S, Nakao A. Okamura Y, et al. Among authors: sugimoto h. Ann Surg Oncol. 2011 Feb;18(2):572-9. doi: 10.1245/s10434-010-1273-z. Epub 2010 Aug 24. Ann Surg Oncol. 2011. PMID: 20734148

8

Promoter hypermethylation of fibulin 1 gene is associated with tumor progression in hepatocellular carcinoma.

Kanda M, Nomoto S, Okamura Y, Hayashi M, Hishida M, Fujii T, Nishikawa Y, Sugimoto H, Takeda S, Nakao A. Kanda M, et al. Among authors: sugimoto h. Mol Carcinog. 2011 Aug;50(8):571-9. doi: 10.1002/mc.20735. Epub 2011 Jan 25. Mol Carcinog. 2011. PMID: 21268132

9

Impact of the thoracoabdominal approach on peri- and postoperative outcomes of hepatectomy for hepatocellular carcinoma.

Okamura Y, Takeda S, Fujii T, Sugimoto H, Nomoto S, Nakao A. Okamura Y, et al. Among authors: sugimoto h. World J Surg. 2011 May;35(5):1042-9. doi: 10.1007/s00268-011-1023-9. World J Surg. 2011. PMID: 21384240

10

Prognostic significance of postoperative complications after hepatectomy for hepatocellular carcinoma.

Okamura Y, Takeda S, Fujii T, Sugimoto H, Nomoto S, Nakao A. Okamura Y, et al. Among authors: sugimoto h. J Surg Oncol. 2011 Dec;104(7):814-21. doi: 10.1002/jso.21977. Epub 2011 Jun 28. J Surg Oncol. 2011. PMID: 21713775

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,729 results

Search Page

Filters